NDC 50419-524-01 - Betaseron

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 50419-524
Requested NDC: 50419-524-01
Package NDCs from labels: 50419-524-01, 50419-524-35, 50419-524-05, 50419-524-09, 50419-524-81
Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Effective date: 2026-03-03
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Betaseron - Bayer HealthCare Pharmaceuticals Inc.	Bayer HealthCare Pharmaceuticals Inc.	2026-03-03	HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50419-524-05	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-08-20	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-07-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-05	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-09	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-35	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993
50419-524-81	2024-01-30	These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON. BETASERON (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50419-524-01	Betaseron	1 in 1 CARTON	KIT	1	29
50419-524-05	Betaseron	5 in 1 BOX	KIT	5	29
50419-524-09	Betaseron	1 in 1 BOX	KIT	1	29
50419-524-35	Betaseron	14 in 1 BOX	KIT	14	29
50419-524-81	Betaseron	14 in 1 BOX	KIT	14	29

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50419-524	BETASERON (INTERFERON BETA-1B) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]	23	Current NDC, Legacy NDC, 5 package rows	20240821_66311f74-0472-4fa3-848a-06002ca0def5.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50419-524-01	EA - Each	50419-524	c38dd881-23ee-4f5a-b0a7-f7ea716f041f	1	2013-12-02
50419-524-35	EA - Each	50419-524	bfbe2cc2-fb88-4a78-8415-f62752bf93e5	1	2013-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
INTERFERON BETA-1B	ACTIVE INGREDIENT	TTD90R31WZ	BETASERON (INTERFERON BETA-1B) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]	3
INTERFERON BETA-1B	ACTIVE MOIETY	TTD90R31WZ	BETASERON (INTERFERON BETA-1B) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]	3
ALBUMIN HUMAN	INACTIVE INGREDIENT	ZIF514RVZR	BETASERON (INTERFERON BETA-1B) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]	3
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	BETASERON (INTERFERON BETA-1B) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]	3
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	BETASERON (INTERFERON BETA-1B) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]	3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 8 of 44 · 870 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Allergy Kids	URTICA DIOICA LEAF, INULA HELENIUM ROOT, ANGELICA ARCHANGELICA ROOT, PINE NEEDLE OIL (PINUS SYLVESTRIS), SODIUM CHLORIDE, AND ALTHAEA OFFICINALIS ROOT	Forces of Nature	4886109c-dd7d-40c0-911f-5f12343d8e63	2026-02-20	Warnings	Exact identifier unii: 451W47IQ8X
Allergy Maximum Strength	URTICA DIOICA, ALTHAEA OFFICINALIS ROOT, INULA HELENIUM ROOT, ANGELICA ARCHANGELICA ROOT, PINE NEEDLE OIL (PINUS SYLVESTRIS), SODIUM CHLORIDE, AND SILICON DIOXIDE	Forces of Nature	122ca23e-43f1-4e5c-afc2-1418b1717679	2026-02-20	Warnings	Exact identifier unii: 451W47IQ8X
Back Pain Pain Management	ARNICA MONTANA, HORSE CHESTNUT, HYPERICUM PERFORATUM, RUTA GRAVEOLENS WHOLE, AND SODIUM CHLORIDE	Forces of Nature	bf089347-f334-4d6d-ab58-cf7f0b16810f	2026-02-20	Warnings	Exact identifier unii: 451W47IQ8X
RHODODIUM	ACTEA RACEMOSA, APIS MELL, CALC CARB, GRAPHITES, IODIUM, NATRUM MUR, PULSATILLA, RHODODENDRON	BM Private Limited	3b3bcba2-6f9e-cd94-e063-6394a90a7701	2026-02-15	Warnings	Exact identifier unii: 451W47IQ8X
Walgreens ULTRA FINE MOISTURIZING SALINE MIST	NASAL MIST	WALGREEN COMPANY	48fef521-1b1d-d0d5-e063-6394a90ac7b1	2026-02-10	Warnings	Exact identifier unii: 451W47IQ8X
Walgreens SALINE MIST	NASAL MIST	WALGREEN COMPANY	44815675-cc1d-a582-e063-6394a90ae8f6	2026-02-10	Warnings	Exact identifier unii: 451W47IQ8X
0.9 percentsaline	SODIUM CHLORIDE	Huizhou Jinsheng Medical Technology Co., Ltd	487cb4fc-2e0b-020f-e063-6294a90a4526	2026-02-03	Warnings	Exact identifier unii: 451W47IQ8X
0.9saline	SODIUM CHLORIDE	Huizhou Jinsheng Medical Technology Co., Ltd	49e76aca-ca2b-3b95-e063-6394a90a875e	2026-02-03	Warnings	Exact identifier unii: 451W47IQ8X
0.9%saline	SODIUM CHLORIDE	Huizhou Jinsheng Medical Technology Co., Ltd	49e7b329-e4e5-6991-e063-6294a90ac817	2026-02-03	Warnings	Exact identifier unii: 451W47IQ8X
Adrenal Support	ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM	NaturalCare	cee52757-a86e-4251-b65f-954ac85f4e7e	2026-01-30	Warnings	Exact identifier unii: 451W47IQ8X
Vital Female Sexual Energy	AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS	Liddell Laboratories, Inc.	7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3	2026-01-30	Warnings	Exact identifier unii: 451W47IQ8X
Additive Formula 3	DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE	Terumo BCT, Ltd	9a5247a1-cc05-442d-b2d0-950f887f03c2	2026-01-30	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
CVS ULTRA FINE MOISTURIZING SALINE MIST	NASAL MIST	CVS	44821c47-63f9-5d0a-e063-6394a90a555d	2026-01-29	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	Nephron Pharmaceuticals Corporation	a4edf2d5-a9ff-30d4-e053-2995a90a5650	2026-01-26	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	ProPharma Distribution	48d73434-e65b-dc98-e063-6294a90affa2	2026-01-20	Adverse reactions	Exact identifier unii: 451W47IQ8X
Equate Comfort Flow Sinus wash	SINUS WASH	WALMART INC	9e911eef-ca99-9902-e053-2a95a90aab0e	2026-01-19	Warnings	Exact identifier unii: 451W47IQ8X
EQUATE PREMIUM SALINE	SODIUM CHLORIDE 0.65%	Walmart Stores, Inc.	1e17f022-f513-140d-e063-6394a90a379e	2026-01-19	Warnings	Exact identifier unii: 451W47IQ8X
Sodium chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	d98bf9f7-30ec-4927-a577-cabad192cb18	2026-01-19	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X
Sodium Chloride Hypertonicity	SODIUM CHLORIDE	CVS Pharmacy	9245d842-7f78-42d8-83ba-8eb9ec8dbc0d	2026-01-15	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride Hypertonicity	SODIUM CHLORIDE	CVS PHARMACY	d5cc6cd1-ddf8-4f5b-a021-204cdda0db94	2026-01-15	Warnings	Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.